[1]蔡兴魁 张占林 马梅芳 徐艳红 安永东.甘肃省临夏地区东乡族和汉族人群甲状腺结节的患病率及危险因素分析[J].国际内分泌代谢杂志,2023,43(05):401-406.[doi:10.3760/cma.j.cn121383-20230402-04001]
　Cai Xingkui,Zhang Zhanlin,Ma Meifang,et al.Epidemiological investigation of thyroid nodules in Dongxiang and Han populations in Linxia area of Gansu province[J].International Journal of Endocrinology and Metabolism,2023,43(05):401-406.[doi:10.3760/cma.j.cn121383-20230402-04001]
点击复制

甘肃省临夏地区东乡族和汉族人群甲状腺结节的患病率及危险因素分析()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
43
期数:
2023年05期
页码:
401-406
栏目:
论著
出版日期:
2023-09-20

文章信息/Info

Title:
Epidemiological investigation of thyroid nodules in Dongxiang and Han populations in Linxia area of Gansu province
作者:
蔡兴魁 张占林 马梅芳 徐艳红 安永东
临夏州人民医院,临夏 731100
Author(s):
Cai Xingkui;  Zhang Zhanlin;  Ma Meifang;  Xu Yanhong;  An Yongdong.
The People's Hospital of Linxia, Linxia 731100, China
关键词:
甲状腺结节;  东乡族;  汉族;  患病率;  危险因素
Keywords:
Thyroid nodules;  Dongxiang nationality;  Han nationality;  Prevalence;  Risk factors
DOI:
10.3760/cma.j.cn121383-20230402-04001
摘要:
目的 调查甘肃省临夏地区东乡族和汉族人群甲状腺结节的患病情况,分析其危险因素。方法 以甘肃省临夏地区18岁以上的东乡族和汉族常住居民为研究对象,收集人口学资料,行甲状腺B超及实验室检查,分为甲状腺结节组和非甲状腺结节组,Logistic回归分析其影响因素。结果 共纳入1 724名研究对象,甲状腺结节患病率为37.5%,其中东乡族为34.1%,汉族为39.7%(P<0.05); 年龄≥50岁、肾小球滤过率降低、糖尿病、游离甲状腺素偏高为甲状腺结节的独立危险因素(P<0.05),而东乡族、男性、少食富碘食物是甲状腺结节的独立保护因素(P<0.05)。结论 汉族人群患病率高于东乡族,针对危险因素,采取预防性措施,对减少甲状腺结节的发生发展至关重要。
Abstract:
Objective To investigate the prevalence and risk factors of thyroid nodules in Dongxiang and Han ethnic groups in Linxia area of Gansu province.Methods The permanent residents of two ethnic groups over 18 years old in Linxia of Gansu province were selected as the research objects. The demographic data, thyroid B- ultrasound and laboratory examination were performed. All subjects were divided into thyroid nodule group and non-thyroid nodule group, and the influencing factors were analyzed by Logistic regression.Results A total of 1 724 subjects were included in the study. The prevalence of thyroid nodules was 37.5%, with 34.1% in Dongxiang ethic group and 39.7% in Han ethic group(P<0.05). Age≥50 years, decreased glomerular filtration rate, diabetes, and high free thyroxine were independent risk factors for thyroid nodules(P<0.05), while Dongxiang ethic group, male, and less iodine-rich food intake were independent protective factors for thyroid nodules(P<0.05).Conclusions The prevalence of thyroid nodules in Han nationality is higher than that in Dongxiang nationality. It is very important to take preventive measures against risk factors to reduce the occurrence and development of thyroid nodules.

参考文献/References:

[1] American Thyroid Association(ATA)Guidelines Task force on Thyroid Nodules and Differentiated Thyroid Cancer,Cooper DS,Doherty GM,et al.Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J].Thyroid,2009,19(11):1167-1214.DOI:10.1089/thy.2009.0110.
[2] Zhao W,Han C,Shi X,et al.Prevalence of goiter and thyroid nodules before and after implementation of the universal salt iodization program in mainland China from 1985 to 2014:a systematic review and meta-analysis[J].PLoS One,2014,9(10):e109549.DOI:10.1371/journal.pone.0109549.
[3] 中华医学会内分泌学分会,中华医学会外科学分会内分泌学组,中国抗癌协会头颈肿瘤专业委员会,等.甲状腺结节和分化型甲状腺癌诊治指南[J].中华内分泌代谢杂志,2012,28(10):779-797.DOI:10.3760/cma.j.issn.1000-6699.2012.10.002.
[4] Levey AS,Stevens LA,Schmid CH,et al.A new equation to estimate glomerular filtration rate[J].Ann Intern Med,2009,150(9):604-612.DOI:10.7326/0003-4819-150-9-200905050-00006.
[5] 李文钰,黄薇.体检中心甲状腺结节患者流行病学特征及危险因素调查分析[J].河北医药杂志,2019,41(3):456-459.DOI:10.3969/j.issn.1002-7386.2019.03.034.
[6] Li Y,Jin C,Li J,et al.Prevalence of thyroid nodules in China:a health examination cohort-based study[J].Front Endocrinol(Lausanne),2021,12:676144.DOI:10.3389/fendo.2021.676144.
[7] 张启暝,董晓秋,王思明,等.居民碘营养状况及甲状腺结节的危险因素分析[J].中国超声医学杂志,2021,37(2):128-131.
[8] 安亚琼,傅松波,彭苏海,等.甘肃省居民甲状腺结节流行病学调查及相关因素分析[J].兰州大学学报(医学版),2021,47(4):12-17.DOI:10.13885/j.issn.1000-2812.2021.04.003.
[9] 蔡兴魁,杜莉,安永东,等.甘肃省东乡族与汉族人群甲状腺结节状况对比调查[J].甘肃医药,2017,36(5):330-332.DOI:10.15975/j.cnki.gsyy.2017.05.004.
[10] 梁雅莉.2018年临夏州碘缺乏病病情监测分析[J].疾病预防控制通报,2019,34(2):47-49.DOI:10.13215/j.cnki.jbyfkztb.1902004.
[11] 窦瑜贵,王燕玲,曹永琴,等.甘肃省临夏州碘盐措施落实进展评价[J].中国地方病防治杂志,2012,27(3):202-204.
[12] 李玉杰,黄军,李子卓,等.甲状腺结节超声表现与尿碘含量的相关性研究[J].哈尔滨医科大学学报,2018,52(1):62-66.
[13] Fan L,Tan L,Chen Y,et al.Investigation on the factors that influence the prevalence of thyroid nodules in adults in Tianjin,China[J].J Trace Elem Med Biol,2018,50:537-542.DOI:10.1016/j.jtemb.2018.03.004.
[14] Kwong N,Medici M,Angell TE,et al.The influence of patient age on thyroid nodule formation,multinodularity,and thyroid cancer risk[J].J Clin Endocrinol Metab,2015,100(12):4434–4440.DOI:10.1210/jc.2015-3100.
[15] Mazzaferri EL,Management of a solitary thyroid nodule[J].N Engl J Med,1993,328(8):553-559.DOI:10.1056/NEJM199302253280807.
[16] Renehan AG,Tyson M,Egger M,et al.Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies[J].Lancet,2008,371(9612):569-578.DOI:10.1016/S0140-6736(8)60269-X.
[17] Zhang HM,Feng QW,Niu YW,et al.Thyroid nodules in type 2 diabetes mellitus[J].Curr Med Sci,2019,39(4):576-581.DOI:10.1007/s11596-019-2076-5.
[18] 蔡伟聪,雷林,赵仁成,等.深圳市社区居民甲状腺结节的患病情况及影响因素分析[J].中国慢性病预防与控制,2021,29(12):923-927.DOI:10.16386/j.cjpccd.issn.1004-6194.2021.12.010.
[19] 徐海波,王坤林,宰国田.不同甲状腺功能状态与肾功能之间的相关性[J].中国临床研究,2018,31(9):1247-1249.DOI:10.13429/j.cnki.cjcr.2018.09.024.

相似文献/References:

[1]杨成会,缪珩.二甲双胍在甲状腺疾病治疗中的作用[J].国际内分泌代谢杂志,2015,(04):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
　Yang Chenghui,Miao Heng..Roles of metformin in the treatment of thyroid diseases[J].International Journal of Endocrinology and Metabolism,2015,(05):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
[2]梁绮君 余寿益 李淑华 胡晨鸣 杨焱.甲状腺结节与代谢综合征的相关性研究[J].国际内分泌代谢杂志,2015,(05):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
　Liang Qijun,Yu Shouyi,Li Shuhua,et al.Association of thyroid nodule and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2015,(05):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
[3]郑仁东 张会峰 胡咏新 曹雯 曹琳 孙洪平 褚晓秋 刘克冕 刘超.男性2型糖尿病患者甲状腺结节 与内分泌激素的相关性研究[J].国际内分泌代谢杂志,2018,38(04):222.[doi:10.3760/cma.j.issn.1673-4157.2018.04.002]
　Zheng Rendong,Zhang Huifeng,Hu Yongxin,et al.Association of thyroid nodules with endocrine hormones in male patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(05):222.[doi:10.3760/cma.j.issn.1673-4157.2018.04.002]
[4]陈茉 徐书杭 刘超.良性甲状腺结节的热消融治疗进展[J].国际内分泌代谢杂志,2019,39(04):248.[doi:10.3760/cma.j.issn.1673-4157.2019.04.008]
　Chen Mo,Xu Shuhang,Liu Chao.Advancement of thermal ablation on benign thyroid nodules[J].International Journal of Endocrinology and Metabolism,2019,39(05):248.[doi:10.3760/cma.j.issn.1673-4157.2019.04.008]
[5]周一帆 季沁 陈国芳 褚晓秋 陈茉 丁文波 胡欣 相萍萍 曾铮 王建华 徐书杭 刘超.TI-RADS对细胞学结果不确定甲状腺结节的诊断价值[J].国际内分泌代谢杂志,2019,39(04):226.[doi:10.3760/cma.j.issn.1673-4157.2019.04.003]
　Zhou Yifan,Ji Qin,Chen Guofang,et al.Clinical value of TI-RADS in the diagnosis of thyroid nodules with indeterminate cytology[J].International Journal of Endocrinology and Metabolism,2019,39(05):226.[doi:10.3760/cma.j.issn.1673-4157.2019.04.003]
[6]周一帆 王建华 徐书杭.甲状腺细胞病理学Bethesda报告系统的更新及研究进展[J].国际内分泌代谢杂志,2020,40(03):175.[doi:10.3760/cma.j.issn.1673-4157.2020.03.007]
　Zhou Yifan,Wang Jianhua,Xu Shuhang.Update and research progress of the Bethesda system for reporting thyroid cytopathology[J].International Journal of Endocrinology and Metabolism,2020,40(05):175.[doi:10.3760/cma.j.issn.1673-4157.2020.03.007]
[7]杨晶晶,徐书杭,刘超.针穿活检用于甲状腺结节诊断的研究进展[J].国际内分泌代谢杂志,2021,41(01):20.[doi:10.3760/cma.j.cn121383-20200511-05018]
　Yang Jingjing,Xu Shuhang,et al.Update on core needle biopsy in the diagnosis of thyroid nodules[J].International Journal of Endocrinology and Metabolism,2021,41(05):20.[doi:10.3760/cma.j.cn121383-20200511-05018]
[8]田勍,洪天配.甲状腺结节诊治过程中的难点与应对[J].国际内分泌代谢杂志,2021,41(06):557.[doi:10.3760/cma.j.cn121383-20210727-07074]
　Tian Qing,Hong Tianpei..Difficulties and countermeasures in the diagnosis and treatment of thyroid nodules[J].International Journal of Endocrinology and Metabolism,2021,41(05):557.[doi:10.3760/cma.j.cn121383-20210727-07074]
[9]张雅,相萍萍,徐书杭,等.经皮无水乙醇注射治疗甲状腺结节:老方法的新认识[J].国际内分泌代谢杂志,2022,42(06):469.[doi:10.3760/cma.j.cn121383-20210926-09075]
　Zhang Ya,Xiang Pingping,Xu Shuhang,et al.Percutaneous ethanol ablation for thyroid nodules: new perspectives on an old paradigm[J].International Journal of Endocrinology and Metabolism,2022,42(05):469.[doi:10.3760/cma.j.cn121383-20210926-09075]
[10].甲状腺结节和分化型甲状腺癌诊治指南(第二版)[J].国际内分泌代谢杂志,2023,43(02):149.[doi:10.3760/cma.j.cn311282-20221023-00589]
　Chinese Society of Endocrinology,Thyroid and Metabolism Surgery Group of the Chinese Society of Surgery,China Anti-Cancer Association,et al.Guidelines for the Diagnosis and Management of Thyroid Nodules and Differentiated Thyroid Cancer(Second Edition)[J].International Journal of Endocrinology and Metabolism,2023,43(05):149.[doi:10.3760/cma.j.cn311282-20221023-00589]

备注/Memo

备注/Memo:
通信作者:安永东,Email:anyongdong7046@163.com
基金项目:甘肃省重点研发计划(20YF3FN047)
更新日期/Last Update: 2023-10-10